Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Superio Bio AS
AS
Active
Org 935412242
Gaustadalléen 21, 0349
Oslo
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2025 · 1 year old
— employees
Monitor
Share
Norway
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Superio Bio AS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
JT
Jan Terje Andersen
Chief Executive Officer
Chief Executive Officer
2026
Board of directors
Non-executive oversight
Name
Role
Member since
Current (4)
AK
Aina Karen Anthi
Board of Directors
Board of Directors
2025
JT
Jan Terje Andersen
Board of Directors
Board of Directors
2025
IS
Inger Sandlie
Chairman
Chairman
2025
PH
Peter Horn Møller
Board of Directors
Board of Directors
2025
Former (1)
TL
Trude Løvås Husjord
Chairman
Chairman
2025 – 2025
Shareholders
As of last annual report
Bioinvent Holding As — 33.25%
Ak Anthi As — 23.75%
Sandlie As — 14.25%
Inven2 As — 5%
76%
Shareholder
Type
Ownership
Votes
Since
Bioinvent Holding As
Company
33.25%
33.25%
2025
Ak Anthi As
Company
23.75%
23.75%
2025
Sandlie As
Company
14.25%
14.25%
2025
Inven2 As
Company
5%
5%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Superio Bio AS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network